Alkem Laboratories has debuted at Rs 1380.00 on the BSE, up by 330 points or 31.43% from its issue price of Rs 1050.
The scrip is currently trading at Rs 1383.15, up by 333.15 points or 31.73% from its issue price and has touched a high and low of Rs 1401.40 and Rs 1355.40. So far 6,42,000 shares were traded on the counter.
The issue price of Alkem Laboratories was fixed at Rs 1050 per share i.e. at the higher end of the price band of Rs 1020-1050 apiece. The offering was subscribed 44.29 times.
The objects of the offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of 12,853,442 Equity Shares by the Selling Shareholders.
Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. Alkem Labs produces branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which they market in India and 55 countries internationally, primarily the United States.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |